Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-EN | Version v6-FR | |
---|---|---|
Language | English | French |
Date Updated | 2019-08-30 | 2019-08-01 |
Drug Identification Number | 02458063 | 02458063 |
Brand name | VENCLEXTA | VENCLEXTA |
Common or Proper name | Venclexta Start pack | Venclexta Start pack |
Company Name | ABBVIE CORPORATION | ABBVIE CORPORATION |
Ingredients | VENETOCLAX VENETOCLAX VENETOCLAX | VENETOCLAX VENETOCLAX VENETOCLAX |
Strength(s) | 10MG 100MG 50MG | 10MG 100MG 50MG |
Dosage form(s) | KIT TABLET | KIT TABLET |
Route of administration | ORAL | ORAL |
Packaging size | 4x7day wallet | 4x7day wallet |
ATC code | L01XX | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | 2019-05-14 | 2019-05-14 |
Actual start date | 2019-05-14 | 2019-05-14 |
Estimated end date | 2019-09-18 | 2019-09-03 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | To ensure continuity of supply across all jurisdictions, and to avoid unnecessary stockpiling, orders will be processed to supply minimal quantity required. This will ensure that we meet patient needs. | To ensure continuity of supply across all jurisdictions, and to avoid unnecessary stockpiling, orders will be processed to supply minimal quantity required. This will ensure that we meet patient needs. |
Health Canada comments |